Page last updated: 2024-08-25

dehydrocostus lactone and Pulmonary Fibrosis

dehydrocostus lactone has been researched along with Pulmonary Fibrosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chai, G; Che, H; Cui, X; Ge, G; Jiang, X; Nie, Y; Sun, H; Wang, Y; Xiong, Y; Zhao, P; Zhou, Y	1

Other Studies

1 other study(ies) available for dehydrocostus lactone and Pulmonary Fibrosis

Article	Year
Dehydrocostus lactone inhibits BLM-induced pulmonary fibrosis and inflammation in mice via the JNK and p38 MAPK-mediated NF-κB signaling pathways. International immunopharmacology, 2021, Volume: 98 Topics: Animals; Bleomycin; Cells, Cultured; Disease Models, Animal; Humans; Lactones; Lung; Macrophage Activation; Male; MAP Kinase Signaling System; Mice; NF-kappa B; Primary Cell Culture; Pulmonary Fibrosis; Sesquiterpenes	2021

Article

Year

Dehydrocostus lactone inhibits BLM-induced pulmonary fibrosis and inflammation in mice via the JNK and p38 MAPK-mediated NF-κB signaling pathways.

International immunopharmacology, 2021, Volume: 98

Topics: Animals; Bleomycin; Cells, Cultured; Disease Models, Animal; Humans; Lactones; Lung; Macrophage Activation; Male; MAP Kinase Signaling System; Mice; NF-kappa B; Primary Cell Culture; Pulmonary Fibrosis; Sesquiterpenes

2021